Literature DB >> 31999619

MANAGEMENT OF ENDOCRINE DISEASE: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion.

Jacques Young1, Magalie Haissaguerre2, Oceana Viera-Pinto1, Olivier Chabre3, Eric Baudin4, Antoine Tabarin2.   

Abstract

Ectopic ACTH syndrome (EAS) is rare but is frequently a severe condition because of the intensity of the hypercortisolism that may be dissociated from the tumoral condition. EAS should often be considered as an endocrine emergency requiring an emergency response both in terms of diagnostic procedures and therapeutic interventions. Patient management is complex and necessitates dual skills, in the diagnosis and treatment of CS and in the specific management of neuroendocrine tumors (NET). Therefore, initial management should be performed ideally by experienced endocrinology teams in collaboration with specialized hormonal laboratory, modern imaging platforms and intensive care units. Diagnostic procedures vary according to the endocrine and tumoral contexts but should be reduced to a minimum in intense hypercortisolism. Preventive and curative treatments of cortisol-induced comorbidities, non-specific management of hypercortisolism and etiological treatments should be considered simultaneously. Therapeutic strategies vary according to (1.) the intensity of hypercortisolism, the general condition of the patient and associated comorbidities and (2.) the tumoral status, ranging from resectable ACTH secreting tumors to non-resectable metastatic endocrine tumors or occult tumors. The ideal treatment is complete excision of the ACTH-secreting tumor that can be performed rapidly or after preoperative preparation using cortisol-lowering drugs. When this is not possible, the therapeutic strategy should be discussed by a multidisciplinary experienced team in a personalized perspective and include variable combinations of pharmacological agents, bilateral adrenalectomy and non-specific tumoral interventions. Here we discuss the diagnosis and therapeutic strategies including the modern, currently available tools and emphasize on the operational effectiveness of care.

Entities:  

Year:  2020        PMID: 31999619     DOI: 10.1530/EJE-19-0877

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  20 in total

1.  Ectopic adrenocorticotrophic hormone syndrome initially presenting as abnormal mental behavior caused by thymic carcinoid: a case report.

Authors:  Xu Han; Qihe Liu; Yan Yang; Xixian Ke; Cheng Chen
Journal:  Gland Surg       Date:  2022-04

Review 2.  Ectopic Cushing's syndrome due to thymic neuroendocrine tumours: a systematic review.

Authors:  Fernando Guerrero-Pérez; Inmaculada Peiró; Agustina Pia Marengo; Alex Teulé; José Carlos Ruffinelli; Roger Llatjos; Teresa Serrano; Ivan Macia; Nuria Vilarrasa; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2021-05-07       Impact factor: 6.514

3.  Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2020-11-11       Impact factor: 3.889

4.  Patient with respiratory distress, facial oedema and refractory hypokalaemia.

Authors:  Udara Dilrukshi Senarathne; Bolonghoge Krishantha Trixy Priyankara Dayanath; Ramani Punchihewa; Bandu Gunasena
Journal:  BMJ Case Rep       Date:  2021-05-07

5.  Case Report: A Challenging Localization of a Pulmonary Ectopic ACTH-Secreting Tumor in a Patient With Severe Cushing's Syndrome.

Authors:  Andreea Liliana Serban; Lorenzo Rosso; Paolo Mendogni; Arianna Cremaschi; Rita Indirli; Beatrice Mantovani; Mariagrazia Rumi; Massimo Castellani; Arturo Chiti; Giorgio Alberto Croci; Giovanna Mantovani; Mario Nosotti; Emanuele Ferrante; Maura Arosio
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-09       Impact factor: 5.555

6.  Mucosal Neuroma Cues for Endocrine Emergency Treatment.

Authors:  Gyu Gang Choi; Hwan Jin Lee; Hyo Jin Han; Young Beom Jeong; Heung Bum Lee; Ji Hyun Park
Journal:  Endocrinol Metab (Seoul)       Date:  2021-12-03

Review 7.  Bronchial Carcinoids: From Molecular Background to Treatment Approach.

Authors:  Marta Araujo-Castro; Eider Pascual-Corrales; Javier Molina-Cerrillo; Nicolás Moreno Mata; Teresa Alonso-Gordoa
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

8.  ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome.

Authors:  John Newell-Price; Lynnette K Nieman; Martin Reincke; Antoine Tabarin
Journal:  Eur J Endocrinol       Date:  2020-07       Impact factor: 6.558

Review 9.  Cushing's syndrome due to adrenocorticotropic hormone-secreting metastatic neuroendocrine tumor of unknown primary origin: a case report and literature review.

Authors:  Hayri Bostan; Hakan Duger; Pinar Akhanli; Murat Calapkulu; Tugba Taskin Turkmenoglu; Ayse Kevser Erdol; Serap Akcali Duru; Muhammed Erkam Sencar; Muhammed Kizilgul; Bekir Ucan; Mustafa Ozbek; Erman Cakal
Journal:  Hormones (Athens)       Date:  2021-09-03       Impact factor: 2.885

10.  Case Report: Three Rare Cases of Ectopic ACTH Syndrome Caused by Adrenal Medullary Hyperplasia.

Authors:  Yu Cheng; Jie Li; Jingtao Dou; Jianming Ba; Jin Du; Saichun Zhang; Yiming Mu; Zhaohui Lv; Weijun Gu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-01       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.